 NEW YORK, March 10, 2021 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a patient focused clinical stage biopharmaceutical company, today announced the closing of its previously announced private placement of common stock and warrants to purchase shares of common stock priced at-the-market under Nasdaq rules, resulting in gross proceeds to the Company of 15.0 million. The Company sold and issued an aggregate of 7,594,937 shares of its common stock or common stock equivalents in lieu thereof and warrants to purchase up to an aggregate of 7,594,937 shares of common stock in the private placement, at a purchase price of 1.975 per share of common stock and associated warrant. 